Kitsize | 12x8 |
Method | ELISA |
Incubationtime | 1x1h(RTS),1x30min(RTS),1x15min |
Standardrange | 42-1050ng/mL(1:21dil.)or20-500ng/mL(1:10dil.) |
Specimen/Volumes | 10µLSerumorPlasma |
Substrate/isotope | TMB,450nm |
RegulatoryStatus: | EU:CE |
Anon-extractionassaywith
highspecificity
Themeasurementofinsulin-likegrowthfactor-I(IGF-I)inserumisofespeciallyhighutilityinthediagnosticwork-upofgrowthdisturbances,particularlywithregardtohumangrowthhormone(hGH)deficiencyoracromegaly.ThemostimportantadvantageofmeasuringIGF-IoverhGHareitsstablecircADIanlevels,i.e.evenasinglemeasurementisofconclusivesignificance.
Inviewoftheabove,measurementofIGF-Ishouldbeputonthefrontburnerinlaboratorydiagnosticwork-up.
TheadvantagesofourELISAsare:
- non-extractionassay;
- highspecificityforIGF-I;
- nointerferencefromIGF-bindingproteins(IGFBP);
- onlyasamplevolumeof10µLrequired;
- onesampledilutionsuffices(usually1:21);
- calibratedagainsttheinternationalstandardofWHONIBSC02/254;
- veryhighsensitivity(0.09ng/mL);
- outstandingaccuracy--98.7%recovery;
- remarkableprecision:inter-assayvarianceof6.8%andintra-assayvarianceof6.7%.
IBLInternational´sIGF-Ienzymelinkedimmunosorbentassay(ELISA)byIBLInternationalisusedformeasuringIGF-Iinhumanserum/plasma,cerebrospinalfluidandotherbodyfluidsaswellasinconditionedcellculturemediaofmanyhumancelllines.
Whatismore,theassaycanalsobeusedforthemeasurementofIGF-Iinothermammalssuchasprimates,cattle,pig,sheep,horse,donkey,goat,dog,cat,rabbitandguineapig.However,thekitisnotsuitedforrat,mouseandchickensamples
Insulin-likegrowthfactorsIandII(IGF-I,IGF-II)playakeyroleinproliferation,differentiationandspecificfunctionsofmanycelltypes.IGF-IisidenticaltosomatomedinC(Sm-C)andisregulatedbythegrowthhormone(hGH/GH)andnutrition.Unlikemanyotherpeptidehormones,IGFsareboundtospecificbindingproteins(IGFBP)withahighaffinity.AsubstantialprobleminthemeasurementofIGF-IlevelsistheinterferencebyIGFBPs.Whenmeasuredinuntreatedserumsamples,inaccurateresultsareobtainedduetotheextremelyslowdissociationoftheIGF-I/IGFBP-3complexduringassayincubation.Forthisreason,onlyafractionofIGF-Iisavailableformeasurement.InterferencesaredeterminedbytheIGF-ItoIGFBPratiointhesample.
Inordertocircumventthisproblem,asimpleassaywasdevelopedinwhichsamplesareacidifiedanddilutedusingabufferofaspecialcompositionpriortoperformingELISA.
ClinicalSignificance
ApartfromhGH,anumberofotherfactorsaffectserumIGF-Ilevels.Lowvaluesarefoundinmalnutrition/malabsorption,hypothyroidism,liverdisease,untreateddiabetesmellitus,chronicinflammatorydiseases,malignanciesandmultipletrauma.Elevatedlevels,ontheotherhand,arefoundinprecociouspubertyandobesity.
InordertobeabletocorrectlyinterpretIGFmeasurements,itisofutmostimportancetoconsidertheage-dependentpatternofIGF-1levels,whichyoucanfindintheInstructionforUse.
Percentiles | |||||
Pubertätsstadium | 0.1th | 5th | 50th | 95th | PubertalStage |
1 | 61 | 105 | 186 | 330 | 1 |
2 | 85 | 156 | 298 | 568 | 2 |
3 | 113 | 196 | 352 | 631 | 3 |
4 | 171 | 268 | 431 | 693 | 4 |
5 | 165 | 263 | 431 | 706 | 5 |